Corporate earnings show mixed H1 2026 results across multiple sectors

Various companies have reported their first-half 2026 financial results, showing a mix of growth and significant losses.

In Morocco, T2S reported strong growth in adjusted profits, driven by public sector sales for healthcare modernization and expansion in Francophone Africa. Conversely, Promopharm issued a profit warning, forecasting a 74% drop in net profit to 6.7 million dirhams due to investments in a new injectable products factory and increased R&D costs.

In Mauritius, MCB Group reported a solid net profit of Rs 20.1 billion, an 11.3% increase from the previous year, despite higher tax rates. In France, GenSight Biologics reported a widening net loss and a negative reported turnover of -1.2 million euros, although it collected 6.5 million euros through patient access programs.

In Tunisia, ASSAD reported a net loss of 18.02 million dinars, largely due to a 16 million dinar debt recognized toward Tunisian customs. Meanwhile, in Cyprus, Mitsides Public Company Ltd saw a 14% increase in profit to €727,134, despite a slight decline in overall sales.